Eventide Asset Management’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $11.9M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $3.27M | Sell |
|
|||||
|
2022
Q4 | $7.22M | Hold |
|
|||||
|
2022
Q3 | $9.06M | Hold |
|
|||||
|
2022
Q2 | $14.9M | Sell |
|
|||||
|
2022
Q1 | $29M | Hold |
|
|||||
|
2021
Q4 | $39.9M | Buy |
|
|||||
|
2021
Q3 | $35.6M | Hold |
|
|||||
|
2021
Q2 | $31.9M | Buy |
|
|||||
|
2021
Q1 | $22.3M | Sell |
|
|||||
|
2020
Q4 | $34.4M | Buy |
|
|||||
|
2020
Q3 | $19.1M | Buy |
|
|||||
|
2020
Q2 | $7.02M | Buy |
|